Targeting Alzheimer cell mitochondria via nilotinib as a therapeutic approach.

Research output: Contribution to conferenceAbstract

Original languageAmerican English
StatePublished - 2018
EventAlzheimer's Drug Discovery Foundation (ADDF) - Washington, United States
Duration: Feb 4 2018Feb 6 2018

Conference

ConferenceAlzheimer's Drug Discovery Foundation (ADDF)
Country/TerritoryUnited States
CityWashington
Period2/4/182/6/18

Cite this